Home> Regulatory Information

  • China Medical Device Standards Management Annual Report (2023)

    2024-05-11

    In 2023, China NMPA approved and issued 117 industry standard projects for medical devices, which were divided into formulation projects (57, 48.7%) and revision projects (60, 51.3%) according to the formulation and revision of standards.

  • Reagents for Detection of Influenza A Viruses Approved by China NMPA

    2024-02-01

    So far, China NMPA has approved a total of 66 reagents for detection of influenza A viruses, including 23 antigen detection products, 5 antibody detection products, and 38 nucleic acid detection products.

  • Rules for Labels of Prepared Slices of Chinese Crude Drugs Issued by China NMPA

    2023-07-14

    The NMPA organized to formulate the Rules for Labels of Prepared Slices of Chinese Crude Drugs, which is hereby released and shall be implemented since August 1, 2024.

  • Chinese drug regulators launch safety crackdown

    2023-06-29

    China's National Medical Products Administration has recently launched a nationwide drug safety consolidation and enhancement campaign to establish a solid foundation for drug safety.

  • Supervision tightened on cosmetic medicine

    2023-05-15

    Eleven central departments including the State Administration for Market Regulation, the National Health Commission and the Ministry of Public Security recently released a guideline to strengthen supervision of the medical cosmetology industry to regulate the industry's development and protect consumers' rights.

  • Supervision ensures medical products safe

    2023-07-06

    With the sale of medical products online skyrocketing in recent years, the National Medical Products Administration has led a crackdown to ensure only safe and approved products are available for consumers.

1 2 3 ... 19 >